Minimal Residual Disease Testing Market Worth $2.3 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In August 2022, Roche launched the Digital LightCycler System, the company’s first digital polymerase chain reaction (PCR) system. This next-generation system detects diseases and is designed to accurately quantify trace amounts of specific DNA and RNA targets not typically detectable by conventional PCR methods.
View full press release